This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arturo Carpio, MD; Franklin Santillán, MD; Pietro León, MD; Carlos Flores, MD; W. Allen Hauser, MD
New York, NY

Arch Intern Med. 1997;157(1):129-130.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Del Brutto should not be surprised by the results of our clinical trial of treatment of neurocysticercosis (NC).¹ A series of articles were published in JAMA to "help physicians translate the results of medical research into clinical practice."² In one of them, the authors state that "to the surprise of many and the indignation of a few," well-conducted randomized clinical trials have contradicted the results of less rigorous studies supporting therapies previously considered "standard" practice.³

To address comments related to the sequence of our studies, we must provide a brief background for the current report. In January 1984, we received support from the Consejo Nacional de Universidades y Escuelas Politécnicas del Ecuador (CONUEP), the institution responsible for scientific research in our country, for a project titled "Clinical Aspects of Neurocysticercosis in Ecuador." In this project, we performed a retrospective review of cases treated for NC between 1984 . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?